Mar 6
|
Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst
|
Feb 15
|
Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
|
Feb 15
|
Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
|
Feb 15
|
Intellia, ReCode partner on genetic medicines for cystic fibrosis
|
Feb 15
|
5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
|
Feb 14
|
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2023 Earnings and Company Updates
|
Feb 10
|
Top 11 CRISPR Stocks To Invest In
|
Jan 13
|
The Top Healthcare Stocks to Buy With $100
|
Jan 12
|
Is Intellia Therapeutics (NTLA) Stock a Solid Choice Right Now?
|
Jan 4
|
Intellia Therapeutics Highlights its Three-Year Strategic Priorities and Anticipated 2024 Key Milestones
|
Jan 4
|
Intellia to lay off staff, cut some early research
|
Dec 31
|
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics
|
Dec 31
|
Is Intellia Therapeutics, Inc. (NASDAQ:NTLA) Trading At A 25% Discount?
|
Dec 27
|
13 Most Promising Future Stocks To Buy According To Hedge Funds
|
Nov 28
|
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull Market
|
Nov 6
|
Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners
|
Nov 2
|
Intellia Presents New Interim Data from the Ongoing Phase 1 Study of NTLA-2001 at the 4th International ATTR Amyloidosis Meeting
|
Nov 2
|
1 Supercharged Growth Stock That Could Make You a Millionaire in 10 Years
|
Sep 10
|
Cathie Wood Is Buying These 2 Biotech Stocks Hand Over Fist, and Wall Street Thinks They Could Double
|
Sep 9
|
10 Biotech Stocks with Biggest Upside
|